Hena Divanovic is a Process Development Scientist at Rentschler Biopharma’s ATMP business, where she specializes in optimizing viral vector development, with a focus on downstream processing for gene therapies. Previously, she held a Project Manager role at a pharmaceutical consulting firm, where she worked closely with clients to drive project objectives, support product commercialization strategies, and navigate industry regulations. Hena holds an M.Sc. in biochemical engineering from UCL and an M.Sc. in pharmaceutical science from the University of Sarajevo, along with training in pharmaceutical technology.